Steven de Maat

10PUBLICATIONS
33CO-AUTHORS
HaematologyBiofabricationMedical infection agents (incl. prions)Proteins and peptidesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 25, 2024
Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis.

Hinde El Otmani, Rowan Frunt, Simone Smits

|Aug 12, 2022
VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.

Marc V A van Moorsel, Steven de Maat, Kristof Vercruysse

|Nov 09, 2021
Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis.

Steven de Maat, Chantal C Clark, Arjan D Barendrecht

|Nov 06, 2021
A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs.

Wariya Sanrattana, Thibaud Sefiane, Simone Smits

|Oct 15, 2021
Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.

Wariya Sanrattana, Simone Smits, Arjan D Barendrecht

|May 06, 2021
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema.

Steven de Maat, Kusumam Joseph, Coen Maas

Pageof 2